Target intelligence / Profile preview

Eukaryotic ribosome and translation machinery

Molecular classification
Ribonucleoprotein complex, Enzyme complex, Other
01

Overview

The eukaryotic ribosome and translation machinery is the multi-component system responsible for synthesizing proteins from messenger RNA (mRNA) templates. It consists of the 80S ribosome (comprising 40S and 60S subunits), various eukaryotic initiation factors (eIFs), elongation factors (eEFs), and release factors. This machinery is frequently exploited by viruses to prioritize the synthesis of viral proteins over host proteins, and its dysregulation is a hallmark of many cancers where increased translation of oncogenes supports rapid cell proliferation (Bushell & Sarnow, 2002; Ruggero, 2013). Therapeutic strategies targeting this apparatus include the use of small molecules like omacetaxine mepesuccinate, which inhibits the elongation phase by preventing the correct positioning of aminoacyl-tRNA, and newer agents like zotatifin that target the eIF4A helicase to prevent the assembly of the translation initiation complex (Gandhi et al., 2014; Ernst et al., 2020). While effective in specific contexts like chronic myeloid leukemia or certain solid tumors, targeting the host's fundamental protein synthesis machinery carries a high risk of systemic toxicity, particularly myelosuppression, due to the essential nature of translation in all healthy cells (Robin et al., 2014).

Other names
Host ribosome80S ribosomeHost translational apparatusProtein synthesis machineryEukaryotic translation system
02

Mechanism of action

Inhibition of the peptidyl transferase center, disruption of the eIF4F initiation complex, inhibition of eIF4A RNA helicase activity, or site-specific depurination of 28S rRNA.

03

Biological functions

Protein synthesisTranslation initiationTranslation elongationTranslation terminationmRNA decoding
04

Disease associations

CancerInfectionRibosomopathyNeurodegenerative disease
05

Safety considerations

MyelosuppressionGastrointestinal toxicityNarrow therapeutic windowSystemic toxicity due to inhibition of essential cellular protein synthesisPotential for off-target effects in non-malignant tissues
06

Interacting drugs

Omacetaxine mepesuccinate

6 more in the full profile.

07

Biomarkers

Phospho-eIF4E levels4E-BP1 phosphorylation statusp70S6K activityRibosomal protein S6 phosphorylation

Beyond the preview

Go deeper on Eukaryotic ribosome and translation machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic ribosome and translation machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call